Jamie Macfarlane
CEO & Founder @ Creator Fund
London, United Kingdom
Jamie Macfarlane is a seed investor at Creator Fund in London focused on Biotechnology and Life Science. Jamie Macfarlane is based out of London, England and is the CEO & Founder of Creator Fund. Jamie previously worked at WPP as a Director of Transformation. Jamie Macfarlane attended the Stanford University Graduate School of Business.
- Total investments:
- 8
- Last investment:
- Lead investor:
- 63%
Last updated:
For AI agents: llms.txt
Industries Jamie Macfarlane invests in
Stages Jamie Macfarlane invests in
Countries Jamie Macfarlane invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Biotechnology 4 (50%)
- Life Science 2 (25%)
- Chemical 1 (13%)
- Internet 1 (13%)
- Software 1 (13%)
Stage
- Seed 3 (38%)
- Pre-Seed 3 (38%)
- Series A 1 (13%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Entelo Bio
|
Precision Medicine | $4M / Seed / Apr 24, 2026 | |
| Anzen Industries focuses on biotech innovation, engineering molecular resilience by stabilizing enzymes for industrial reactions. | $2.3M / Pre-Seed / Jan 19, 2026 | ||
| Ovo Labs is developing therapeutics that boost egg quality to enhance IVF success, technology aims to extend the timeline when the chances of conception are high. | $5.3M / Seed / Apr 24, 2025 | ||
| Baseimmune is a biotech startup founded to create the next generation of vaccines. | $11.4M / Series A / Feb 26, 2024 | ||
| Didimi is a developer of a digital twins and information management platform designed for the construction industry. | $944.4K / Pre-Seed / Feb 14, 2024 | ||
| Myria have developed a genetically engineered platform that allows for the discovery of complex natural product molecules which have pharmaceutical applications. They screen tens of millions of compounds for identification and optimisation of drug lead candidates. | $1.9M / Pre-Seed / Jan 05, 2024 | ||
| Baseimmune is a biotech startup founded to create the next generation of vaccines. | $4.8M / Seed / Nov 02, 2021 | ||
| Baseimmune is a biotech startup founded to create the next generation of vaccines. | $947.6K / Seed / Apr 01, 2021 |
Co-Investors
About Creator Fund
Creator Fund invests in founders building companies on the frontier of what's possible. We are deep technology experts and believe before others understand. We think the next generation of technology European unicorns will be built out of university innovation and have teams across 24 campuses to back pioneering scientific founders first.
Creator Fund Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Jamie Macfarlane
CEO & Founder
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Jamie Macfarlane invest in?
Jamie Macfarlane invests primarily in Biotechnology, Life Science and Chemical startups, most often at Seed and Pre-Seed stage. Most of the 8 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Jamie Macfarlane?
Public channels for Jamie Macfarlane include LinkedIn, X (Twitter) and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Jamie Macfarlane last invest?
The most recent investment recorded for Jamie Macfarlane closed in Apr 2026. Shizune tracks 8 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
